Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A brief visual evoked potential (VEP) modulation assessment of experience-dependent plasticity recorded via wireless dry-EEG headset in Phase 1 clinical units.
Journal: Scientific reports
Published: July 11, 2025
TAAR1 Regulates Presynaptic Dopamine Function: Evidence From Preclinical Studies and a Phase 1b Trial in Patients With Schizophrenia.
Journal: Biological psychiatry
Published: May 08, 2025
The trace amine-associated receptor 1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia.
Journal: Biological psychiatry
Published: May 08, 2025
A double-blind study on ulotaront's impact on weight-related parameters in schizophrenia patients with metabolic syndrome and prediabetes: Part II.
Journal: Diabetes, obesity & metabolism
Published: May 04, 2025
An open-label study on ulotaront's effects on insulin-glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I.
Journal: Diabetes, obesity & metabolism
Published: May 03, 2025
Evaluating speech latencies during structured psychiatric interviews as an automated objective measure of psychomotor slowing.
Journal: Psychiatry research
Published: March 29, 2024
TAAR1 agonist ulotaront delays gastric emptying of solids in patients with schizophrenia and concurrent metabolic syndrome with prediabetes.
Journal: Diabetes, obesity & metabolism
Published: February 05, 2024
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding.
Journal: Molecular metabolism
Published: November 29, 2023
A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects.
Journal: Clinical pharmacokinetics
Published: October 02, 2023
The Lifetime Burden of Schizophrenia as Estimated by a Government-Centric Fiscal Analytic Framework.
The Lifetime Burden of Schizophrenia as Estimated by a Government-Centric Fiscal Analytic Framework.
Journal: The Journal of clinical psychiatry
Published: August 09, 2023
Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans.
Journal: Neurology and therapy
Published: January 23, 2023
A randomized, single-dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophrenia.
Journal: Clinical and translational science
Published: December 07, 2022
Last Updated: 09/26/2026